Prolonged β2-agonist treatment enhances muscle-specific glucose uptake in individuals with overweight and obesity: a randomized placebo-controlled trial
-AR stimulation for improving muscle-specific glucose uptake in individuals with or at risk for developing diabetes.
Authors
- Gert Schaart (ORCID: https://orcid.org/0000-0003-4259-9528)
- Froukje Vanweert (ORCID: https://orcid.org/0000-0002-0005-8523)
- Esther Moonen‐Kornips
- Tore Bengtsson (ORCID: https://orcid.org/0000-0002-5396-030X)
- Joris Hoeks (ORCID: https://orcid.org/0000-0002-0265-0870)
- Tineke van de Weijer (ORCID: https://orcid.org/0000-0003-3485-7881)
- Esther Phielix
- Kevin M.R. Nijssen (ORCID: https://orcid.org/0000-0003-4809-554X)
- Kim Brouwers
- Roel Wierts (ORCID: https://orcid.org/0000-0002-9955-8754)
- Vera B. Schrauwen‐Hinderling (ORCID: https://orcid.org/0000-0001-7795-584X)
- Peter J. Joris (ORCID: https://orcid.org/0000-0001-6852-5776)
- Sten M. M. van Beek (ORCID: https://orcid.org/0000-0002-8168-4883)
- Sam Springer
- Pip M. G. Van Lier
- Patrick Schrauwen
Institutions
- Stockholm University (SE)
- Leiden University Medical Center (NL)
- Maastricht University Medical Centre (NL)
- Maastricht University (NL)
- Deutsches Diabetes-Zentrum e.V. (DE)
- German Center for Diabetes Research (DE)
- Heinrich Heine University Düsseldorf (DE)
Publication Details
- Journal
- Nature Communications
- Published
- 2026-04-21
- DOI
- https://doi.org/10.1038/s41467-026-71897-9
- Primary Topic
- Adipose Tissue and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00